Form 4 for EW Edwards Lifesciences
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-14 · accession 0001225208-22-004663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-14 | 2022-03-14 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $104.65 | -20.0K | 27.4K | -42% | -$2.09M |
| D | 2022-03-14 | 2022-03-14 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.4K | +73% | +$435.2K |
| D | 2022-03-14 | 2022-03-14 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | -20.0K | 43.4K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | S | D | 8,147 | $104.31 | 39,267.52 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $103.58 to $104.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-03-14 | S | D | 11,853 | $104.88 | 27,414.52 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $104.58 to $105.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-03-14 | M | A | 20,000 | $21.76 | 47,414.52 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2022-03-14 | M | D | 20,000 | $0.00 | 43,400 | D | $21.76 · 2016-05-14 to 2022-05-13 | 20,000 Common Stock |